Daniel Espes, Associate Professor of Medicine & Senior Consultant in Internal Medicine
Daniel highlights the major global challenges in diabetes care and shows how AI can be a key to overcoming them.
A conversation about life with type 1 diabetes, everyday challenges, essential tools, the impact of technology, and hopes for AI.
Per-Ola explains how AI can enable more personalized treatment and make everyday life easier for both healthcare professionals and people living with diabetes.
Nasim discusses the challenges and opportunities of implementing artificial intelligence in healthcare systems.
Robert shares international insights on how innovation, collaboration, and AI drive change in diabetes care.
The panel gathers Daniel Espes, Per-Ola Carlsson, Nasim Bergman Farrokhnia, and Thomas Magnusson, chairman of Diabetes Sweden, for a cross-sectoral conversation about the future of diabetes care.










